Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy. - Wikidata - awgldk - TriplyDB

Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy.

Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy.

http://www.wikidata.org/entity/Q37420332

about

Translational research of adult stem cell therapy Concise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart Disease Stem cells: An eventual treatment option for heart diseases Magnetic resonance imaging and multi-detector computed tomography assessment of extracellular compartment in ischemic and non-ischemic myocardial pathologies Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease Considerations for pre-clinical models and clinical trials of pluripotent stem cell-derived cardiomyocytes Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions Use of mesenchymal stem cells for therapy of cardiac disease Exosomes in mesenchymal stem cells, a new therapeutic strategy for cardiovascular diseases?Paracrine action of mesenchymal stem cells revealed by single cell gene profiling in infarcted murine hearts Stem cell-derived exosomes as a therapeutic tool for cardiovascular disease Emerging MRI methods in translational cardiovascular research Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation Grafts enriched with subamnion-cord-lining mesenchymal stem cell angiogenic spheroids induce post-ischemic myocardial revascularization and preserve cardiac function in failing rat hearts Does transendocardial injection of mesenchymal stem cells improve myocardial function locally or globally?: An analysis from the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis (POSEIDON) randomized trial.Cardiomyocyte-like cells differentiation from non β-catenin expression mesenchymal stem cells Magnetic Resonance Imaging of Iron Oxide-Labeled Human Embryonic Stem Cell-Derived Cardiac Progenitors Extracellular matrix remodeling following myocardial infarction influences the therapeutic potential of mesenchymal stem cells Mesenchymal stem cell therapy: Two steps forward, one step back Bone marrow mesenchymal stem cells protected post-infarcted myocardium against arrhythmias via reversing potassium channels remodelling.Stem cell therapy for cardiac dysfunction Excitation-contraction coupling in ventricular myocytes is enhanced by paracrine signaling from mesenchymal stem cells.Preservation of myocardial structure is enhanced by pim-1 engineering of bone marrow cells Stem cell therapy and breast cancer treatment: review of stem cell research and potential therapeutic impact against cardiotoxicities due to breast cancer treatment.Intramyocardial transplantation and tracking of human mesenchymal stem cells in a novel intra-uterine pre-immune fetal sheep myocardial infarction model: a proof of concept study Myocardial remodeling: cellular and extracellular events and targets."Second-generation" stem cells for cardiac repair Intracoronary delivery of self-assembling heart-derived microtissues (cardiospheres) for prevention of adverse remodeling in a pig model of convalescent myocardial infarction CT for evaluation of myocardial cell therapy in heart failure: a comparison with CMR imaging New strategies for overcoming limitations of mesenchymal stem cell-based immune modulation.Delayed administration of allogeneic cardiac stem cell therapy for acute myocardial infarction could ameliorate adverse remodeling: experimental study in swine.Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Relieve Acute Myocardial Ischemic Injury.A long road for stem cells to cure sick hearts: update on recent clinical trials.Human mesenchymal stromal cells improve scar thickness without enhancing cardiac function in a chronic ischaemic heart failure model Xenotransplantation of Bone Marrow-Derived Human Mesenchymal Stem Cell Sheets Attenuates Left Ventricular Remodeling in a Porcine Ischemic Cardiomyopathy Model.Translational aspects of cardiac cell therapy.Mesenchymal stem cells for cardiac regeneration: translation to bedside reality Cell-based therapy for prevention and reversal of myocardial remodeling Synergistic Effects of Combined Cell Therapy for Chronic Ischemic Cardiomyopathy Intracoronary Transplantation of Mesenchymal Stem Cells with Overexpressed Integrin-Linked Kinase Improves Cardiac Function in Porcine Myocardial Infarction.

P2860

Q26774565-6CCE538F-7A62-46C7-A5F0-EFCFD567D4F6 Q26774781-A148F07C-F5E9-4FB2-B043-F1F4233690FC Q26782194-FD711290-927C-4D86-BA54-4602C6A6F54C Q26824231-FF395AB9-44FA-4E45-A98E-47F2005B5AD6 Q26865070-56DB5790-BBA7-4209-80E6-20032364DEA2 Q26865173-C1E5A3B7-8C78-43E8-BEC3-1E4663A87B6B Q27001159-CBA840A4-E311-43EC-ADF8-A6D64DF48C20 Q27003127-8D37D540-E2A6-4A9A-A40C-E93339BB2684 Q27009438-6FFEB30A-C9FB-4F07-947E-A8FF6D27347C Q27304850-D2EC79C4-1240-4059-8025-750D654724E8 Q28071466-66E8EDB9-B02A-4F16-96CF-4BEBD7B5EFAE Q30425743-FF8B99D4-859F-4CD0-8C5B-9F7FA1DC0171 Q30523741-FD5A5692-09D5-4217-B981-4F71852E432E Q30559112-93770278-36C8-41BA-B008-1C6238120DD9 Q30581265-7B937F1F-4BA1-40FD-B141-2B9317192627 Q30582814-F32F0AA4-AFD7-4076-B284-11380AB3FB62 Q30696266-32D3E9B5-6693-4202-B2D5-99CD91EADCFF Q33746224-5BB82115-256E-4365-8726-4352BB2F6360 Q33898653-13517876-96EB-4762-A84E-598F0EBFDFEC Q34011512-1AD9B202-0113-4C15-9A0B-2D6B48408B55 Q34129904-46A6E15B-C3C8-46AA-B027-7E4F2ED24BEE Q34215785-CB6418B9-3107-4FF0-993B-1D3306092A67 Q34276744-8C74F97D-6209-44BE-8B23-5A11CCEB26C8 Q34441749-13751973-7232-420D-AB46-B62CA1A85E3D Q34637607-A13F2761-84A2-4568-930C-D131608B67E8 Q35168352-48910CD1-C7B6-4740-BE19-59A0E9B75D27 Q35205665-2FC83D96-1F49-42A5-9EAE-74010D73E995 Q35597418-38752FA3-63F9-4DC5-9C34-304022277A2A Q35632921-108BC8EE-9A8A-40B0-AA45-EC64E5E294D6 Q35653672-85C2500F-5489-43B6-A464-052843E70414 Q35690093-C86A93D6-3A22-4AA4-9235-E6606E29FDA6 Q35708579-A4B681A8-149E-4852-BB7B-13E8DFB2236C Q35794808-7E828781-AD98-411A-A7AA-FF6F57F42041 Q35896781-96826BB1-3AD1-447D-B084-FDFF51E2B67A Q35927940-8F148B17-C65A-4B8B-A6AB-D9D7F1A54CE1 Q35995055-ACF80697-7F1E-466E-9363-807B95F09A1E Q36056155-B55105BB-B57E-4AB2-96B0-460DE6B4B6E2 Q36176132-CE7FA2DA-071A-4166-A730-3261D4F520A5 Q36236436-7841D791-5AF3-4E57-8C48-D0455A607A79 Q36448909-317E7ED3-DB32-4EA1-9069-9649858B20E1

P2860

Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy.

http://www.wikidata.org/entity/Q37420332

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 08 July 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Autologous mesenchymal stem ce ...... onic ischaemic cardiomyopathy.

@en

Autologous mesenchymal stem ce ...... onic ischaemic cardiomyopathy.

@nl

type

label

Autologous mesenchymal stem ce ...... onic ischaemic cardiomyopathy.

@en

Autologous mesenchymal stem ce ...... onic ischaemic cardiomyopathy.

@nl

prefLabel

Autologous mesenchymal stem ce ...... onic ischaemic cardiomyopathy.

@en

Autologous mesenchymal stem ce ...... onic ischaemic cardiomyopathy.

@nl

P1433

Q37420332-38E6AE1C-3220-4C94-BE73-329CB474A46F

P1476

Q37420332-0FF18F13-6B58-4621-B4B8-3E147B18A40D

P2093

Q37420332-008059EB-49E5-491B-8FDD-D3070CF48C74

Q37420332-14448E80-A284-4A0D-9FA2-938800330B9A

Q37420332-20B553A2-AE85-4390-832B-E6C63DC195B6

Q37420332-23116638-F08F-4928-8F8F-6A0998E203EC

Q37420332-3C7CA2DF-9CBA-4EC7-80D1-05FE5EFBCE3B

Q37420332-619A147E-F441-427F-9C00-5DA8667E0803

Q37420332-6AFA6350-817A-48EB-ABA1-22B2BFED38F4

Q37420332-7C0D5CA8-1879-4F81-A281-AF771424ADF9

Q37420332-86A1B523-AA5D-445C-9F11-5B76542F7549

Q37420332-8F3CF1AC-CC11-4C8B-82F5-EE9E8626565C

P2860

Q37420332-06BD04C2-B4C3-4D3D-A78E-CC6FA014CDAA

Q37420332-0FCC82B5-D90A-450B-87AF-421E90D3F4A6

Q37420332-1117D3D4-B35C-44D8-87D7-FA5DE3B9B6A6

Q37420332-1CD62ED3-1B27-4249-8CB2-2EADF1936B6F

Q37420332-23331D14-9DB5-4EDD-B766-D1F3444A831F

Q37420332-2590464F-74AA-4553-A98F-64A746DF7657

Q37420332-2A47B6B7-264A-44A5-B6F7-B15E3D2F39DF

Q37420332-2F6AB6AD-3215-4B64-91FB-6E28B6B84B74

Q37420332-2FC479E2-E547-4CFC-88E1-2533C921A19C

Q37420332-32B9818D-4611-49F5-A182-47F7EFDDE0A4

P304

Q37420332-0AD2F54E-417D-4B7B-88E8-7B9F3B7E0F2C

P31

Q37420332-823E4A44-8D0B-4B3D-8CDA-CB535379832F

P356

Q37420332-48A4AE41-94BC-4278-A819-BB64BD32D0DA

P433

Q37420332-8433C781-71A7-401B-ABC4-B41FE8209061

P478

Q37420332-01C8C319-A267-42DC-AAB5-BD313005C145

P577

Q37420332-93D2C8A1-83CE-43E6-AF85-74115B57B2A6

P5875

Q37420332-C3AEA7D7-62B2-4E6B-80EC-734E25133C8C

P698

Q37420332-E10EDA92-3690-4479-AAF0-85BFCA0379CB

P932

Q37420332-653EA75C-6913-4C1C-AA1B-E12E0DA9F6CA

P356

P1433

European Heart Journal

P1476

Autologous mesenchymal stem ce ...... onic ischaemic cardiomyopathy.

@en

P2093

Albert C Lardo

http://www.w3.org/2001/XMLSchema#string

Barbara Detrick

http://www.w3.org/2001/XMLSchema#string

Charles Steenbergen

http://www.w3.org/2001/XMLSchema#string

Eric S Weiss

http://www.w3.org/2001/XMLSchema#string

Gary S Feigenbaum

http://www.w3.org/2001/XMLSchema#string

Ian McNiece

http://www.w3.org/2001/XMLSchema#string

Jeffrey M Zimmet

http://www.w3.org/2001/XMLSchema#string

Jennifer Turney

http://www.w3.org/2001/XMLSchema#string

John V Conte

http://www.w3.org/2001/XMLSchema#string

Joshua Kellner

http://www.w3.org/2001/XMLSchema#string

P2860

Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction

Multilineage potential of adult human mesenchymal stem cells

Human mesenchymal stem cells modulate allogeneic immune cell responses

Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

Aging of mesenchymal stem cell in vitro.

The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation.

Is stem cell therapy ready for patients? Stem Cell Therapy for Cardiac Repair. Ready for the Next Step .

Clinical epidemiology of heart failure.

Mesenchymal stem cells for cardiac regenerative therapy.

Adult mesenchymal stem cells: a pluripotent population with multiple applications.

P304

2722-2732

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/EURHEARTJ/EHP265

http://www.w3.org/2001/XMLSchema#string

P433

22

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

2009-07-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26656187

http://www.w3.org/2001/XMLSchema#string

P698

19586959

http://www.w3.org/2001/XMLSchema#string

P932

2777027

http://www.w3.org/2001/XMLSchema#string